Agenovir has a total of 71 patents globally, out of which 1 has been granted. Of these 71 patents, more than 5% patents are active. United States of America is where Agenovir has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Agenovir.
Agenovir was founded in the year 2014. The Company operates as a pharmaceutical company. The Company researches and develops a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.
Do read about some of the most popular patents of Agenovir which have been covered by us in this article and also you can find Agenovir patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Agenovir patent portfolio.
How many patents does Agenovir have?
Agenovir has a total of 71 patents globally. These patents belong to 19 unique patent families. Out of 71 patents, 4 patents are active.
How Many Patents did Agenovir File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Agenovir Applications Filed | Agenovir Patents Granted |
2020 | 1 | – |
2019 | 2 | – |
2018 | 8 | 1 |
2017 | 12 | – |
2016 | 48 | – |
How many Agenovir patents are Alive/Dead?
How Many Patents did Agenovir File in Different Countries?
Countries in which Agenovir Filed Patents
Country | Patents |
United States Of America | 17 |
Europe | 9 |
Canada | 8 |
Japan | 7 |
Hong Kong (S.A.R.) | 4 |
China | 3 |
Australia | 3 |
United Kingdom | 2 |
Where are Research Centres of Agenovir Patents Located?
10 Best Agenovir Patents
US20160350476A1 is the most popular patent in the Agenovir portfolio. It has received 44 citations so far from companies like Biomedrex Ab, Synthego Corporation and The Broad Institute, Inc.
Below is the list of 10 most cited patents of Agenovir:
Publication Number | Citation Count |
US20160350476A1 | 44 |
US20160346360A1 | 41 |
WO2017147446A1 | 41 |
WO2016196282A1 | 40 |
US20160348074A1 | 39 |
US20160346362A1 | 39 |
WO2017147432A1 | 39 |
WO2016196273A1 | 39 |
US20170087225A1 | 38 |
WO2016161260A1 | 38 |
What Percentage of Agenovir US Patent Applications were Granted?
Agenovir (Excluding its subsidiaries) has filed 17 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 5.88%.
Below are the key stats of Agenovir patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Agenovir?
Law Firm | Total Applications | Success Rate |
Seed Ip Law Group | 17 | 5.88% |
What are Agenovir key innovation segments?
What Technologies are Covered by Agenovir?
The chart below distributes patents filed by Agenovir